nalidixic acid has been researched along with enoxacin in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 45 (64.29) | 18.7374 |
1990's | 9 (12.86) | 18.2507 |
2000's | 11 (15.71) | 29.6817 |
2010's | 3 (4.29) | 24.3611 |
2020's | 2 (2.86) | 2.80 |
Authors | Studies |
---|---|
Inoue, Y; Jinbo, Y; Kawahata, Y; Kondo, H; Sakamoto, F; Taguchi, M; Tsukamoto, G | 1 |
Domagala, JM; Hanna, LD; Heifetz, CL; Hutt, MP; Mich, TF; Sanchez, JP; Solomon, M | 1 |
Domagala, JM; Heifetz, CL; Mich, TF; Nichols, JB | 1 |
Egawa, H; Matsumoto, J; Minamida, A; Miyamoto, T; Nishimura, H; Nishimura, Y | 1 |
Antón-Fos, GM; Duart, MJ; Mut-Ronda, S; Salabert-Salvador, MT | 1 |
Chen, S; Cui, S; McDermott, PF; Meng, J; Paulsen, I; White, DG; Zhao, S | 1 |
Aubry, A; Cambau, E; Jarlier, V; Matrat, S; Mayer, C | 1 |
Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW | 1 |
Hashida, Y; Konaka, R; Kourai, H; Maseda, H; Shirai, A | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Blaskovich, MAT; Pham, TDM; Ziora, ZM | 1 |
Hoshino, K; Saiki, A; Sawai, T; Yamaguchi, A | 1 |
Hall, MC; Piddock, LJ; Walters, RN | 1 |
Bhattacharya, SS; Lal, HM; Lalitha, MK; Nisha, AK; Ramamoorthy, U | 1 |
Bia, FJ; Divo, AA; Patton, CL; Sartorelli, AC | 1 |
Guimaraes, MA; Noone, P | 1 |
Auckenthaler, R; Michéa-Hamzehpour, M; Pechère, JC | 1 |
Avesani, V; Delmee, M | 1 |
Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL | 2 |
Cremer, AW; Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL; Robbins, MJ; Wall, RA; Williams, AH | 1 |
Baltch, AL; Bassey, CM; Smith, RP | 1 |
Barry, AL; Jones, RN; Thornsberry, C | 1 |
Grimm, H | 1 |
Lior, H; Ng, LK; Taylor, DE | 1 |
Høiby, N | 1 |
Kresken, M; Wiedemann, B | 1 |
Baars, B; Cullmann, W; Opferkuch, W; Stieglitz, M | 1 |
Traub, WH | 2 |
Campbell, ME; Clarke, AM; Zemcov, SJ | 1 |
Cowlishaw, A; Eley, A; Greenwood, D; Slater, G; Teoh-Chan, CH | 1 |
de Moor, G; Lacroix, G; Mambour, A; Rossion, N; Schuyteneer, F; van der Auwera, P | 1 |
Bailey, J; Heppleston, C; Richmond, S | 1 |
Bryskier, A; Devos, J; Dubreuil, L; Romond, C | 1 |
Petrou, MA; Rogers, TR | 1 |
Butzler, JP; De Mol, P; Lagasse, R; Mets, T; Mutwewingabo, A; Vandepitte, J | 1 |
Walker, RC; Wright, AJ | 1 |
King, A; Phillips, I; Shannon, K; Slegg, J | 1 |
King, A; Phillips, I | 1 |
Smith, JT | 1 |
Neu, HC | 1 |
Henry, D; Ngui-Yen, J; Skidmore, AG; Smith, A; Smith, JA | 1 |
Actor, P; Uri, JV | 1 |
Bannatyne, RM; Cheung, R; Toma, S | 1 |
Bauer, D; Häberle, R; Traub, WH | 1 |
Chartrand, SA; Marks, MI; Scribner, RK; Weber, AH; Welch, DF | 1 |
Kashimoto, S; Katae, H; Minami, A; Nakamura, S; Nakata, K; Shimizu, M; Takase, Y; Yamagishi, J | 1 |
Kashimoto, S; Kurobe, N; Nakamura, S; Ohue, T; Shimizu, M; Takase, Y | 1 |
Inoue, M; Kouno, K; Mitsuhashi, S | 1 |
Chin, NX; Neu, HC | 1 |
Barry, AL; Jones, RN | 1 |
Koornhof, HJ; Saunders, J; Shrire, L; Traynor, R | 1 |
Bauernfeind, A; Ullmann, U | 1 |
Adhami, ZN; Lockley, R; Webberly, M; Wise, R | 1 |
Duncan, IB; Marshall, PW; Skulnick, M | 1 |
Chiba, K; Hirano, T; Iwata, K; Miyazaki, S; Nakajima, Y; Oda, M; Sasaya, M; Takada, M | 1 |
Phillips, I; Power, EG | 1 |
Chen, CH; Chiang, HY; Lee, F; Lee, JH; Lee, SH; Liu, YT; Tsou, TL; Wang, TM | 1 |
Chignell, CF; Martínez, L | 1 |
Asuquo, AE; Jin, YF; Piddock, LJ; Ricci, V | 1 |
Hopkała, H; Kowalczuk, D | 1 |
Hayakawa, H; Kawamura, Y; Miyazaki, M; Nagasawa, M; Nakamura, S; Nojima, Y | 1 |
Chiang, CH; Lu, DW; Tai, MC | 1 |
Holzgrabe, U; Kiefer, W; Neugebauer, U; Popp, J; Schmitt, M; Szeghalmi, A | 1 |
Depta, JP; Pichler, WJ; Schmid, DA | 1 |
Romero, IC; Saravia, NG; Walker, J | 1 |
Dasgupta, S; Kumar, A; Ojha, M; Yadav, D; Yadav, R | 1 |
Kondapalli, VG; Mithula, S; Murugesan, S; Nandikolla, A | 1 |
4 review(s) available for nalidixic acid and enoxacin
Article | Year |
---|---|
Quinolone antibiotics.
Topics: | 2019 |
Symposium on antimicrobial agents. The quinolones.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Female; Humans; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1987 |
1,8-Naphthyridine Derivatives: A Privileged Scaffold for Versatile Biological Activities.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Enoxacin; Fluoroquinolones; Gemifloxacin; Humans; Nalidixic Acid; Naphthyridines; Nitrogen; Polypharmacy; Thiazoles | 2021 |
1,8-naphthyridine derivatives: an updated review on recent advancements of their myriad biological activities.
Topics: Animals; Anti-Infective Agents; Antidepressive Agents; Antineoplastic Agents; Antioxidants; Antiviral Agents; Drug Discovery; Enoxacin; Humans; Isomerism; Molecular Structure; Nalidixic Acid; Naphthyridines; Neurodegenerative Diseases; Structure-Activity Relationship; Thiazoles | 2021 |
1 trial(s) available for nalidixic acid and enoxacin
Article | Year |
---|---|
Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.
Topics: Adult; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Dysentery, Bacillary; Enoxacin; Humans; Middle Aged; Nalidixic Acid; Naphthyridines; Prospective Studies; Random Allocation; Shigella dysenteriae; Shigella flexneri | 1987 |
65 other study(ies) available for nalidixic acid and enoxacin
Article | Year |
---|---|
Synthesis and antibacterial activity of new tetracyclic quinolone antibacterials.
Topics: Animals; Anti-Infective Agents; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Microbial Sensitivity Tests; Quinolones; Structure-Activity Relationship | 1992 |
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
Topics: Anti-Bacterial Agents; Bacteria; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Microbial Sensitivity Tests; Naphthyridines; Plasmids; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity.
Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
Pyridonecarboxylic acids as antibacterial agents. 2. Synthesis and structure-activity relationships of 1,6,7-trisubstituted 1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids, including enoxacin, a new antibacterial agent.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Enoxacin; Escherichia coli; Mice; Naphthyridines; Pseudomonas aeruginosa; Staphylococcus aureus; Structure-Activity Relationship | 1984 |
Search compounds with antimicrobial activity by applying molecular topology to selected quinolones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Discriminant Analysis; Drug Design; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones | 2003 |
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
Topics: Animals; Anti-Infective Agents; DNA Topoisomerases; Drug Resistance, Bacterial; Fluoroquinolones; Gene Targeting; Genes, Bacterial; Mutation; Salmonella Infections, Animal; Salmonella typhimurium | 2007 |
Mutagenesis in the alpha3alpha4 GyrA helix and in the Toprim domain of GyrB refines the contribution of Mycobacterium tuberculosis DNA gyrase to intrinsic resistance to quinolones.
Topics: Amino Acid Sequence; Antitubercular Agents; DNA Gyrase; Drug Resistance, Bacterial; Molecular Sequence Data; Mutagenesis, Site-Directed; Mycobacterium tuberculosis; Protein Structure, Secondary; Quinolones; Sequence Homology, Amino Acid; Structure-Activity Relationship | 2008 |
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin | 2008 |
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cetylpyridinium; Disinfectants; Drug Resistance, Multiple, Bacterial; Membrane Proteins; Mutation; Norfloxacin; Quaternary Ammonium Compounds; Serratia marcescens | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
OmpF channel permeability of quinolones and their comparison with beta-lactams.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Cell Membrane Permeability; Cephalosporins; Diffusion; Enoxacin; Escherichia coli; Liposomes; Nalidixic Acid; Norfloxacin; Ofloxacin; Stereoisomerism | 1992 |
Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacter cloacae; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Klebsiella pneumoniae; Mutation; Nalidixic Acid; Phenotype; Quinolones; Serratia marcescens; Species Specificity | 1991 |
Susceptibility pattern of bacterial isolates to lomefloxacin.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Nalidixic Acid; Norfloxacin; Quinolones | 1990 |
Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro.
Topics: Aminocoumarins; Animals; Anti-Infective Agents; Chloroquine; Ciprofloxacin; Coumarins; Drug Interactions; Drug Resistance; Enoxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Oxolinic Acid; Pefloxacin; Plasmodium falciparum; Tetracycline; Topoisomerase II Inhibitors | 1988 |
The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.
Topics: Acinetobacter; Bacteria; Bacterial Infections; Ciprofloxacin; Citrobacter; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Quinolines; Serratia; Staphylococcus | 1986 |
In-vitro activity of newer quinolones against aerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Calcium; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Magnesium Sulfate; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pseudomonas; Quinolines; Sulfates; Zinc; Zinc Sulfate | 1986 |
Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Clostridium; Enoxacin; Fluoroquinolones; Humans; Infant, Newborn; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1986 |
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
Topics: 4-Quinolones; Aeromonas; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter fetus; Cinoxacin; Ciprofloxacin; Diarrhea; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Intestines; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Salmonella; Shigella; Vibrio cholerae; Vibrio parahaemolyticus; Yersinia enterocolitica | 1985 |
The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Topics: 4-Quinolones; Anti-Infective Agents; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Streptococcus pneumoniae | 1985 |
Comparative in vitro studies with 4-quinolone antimicrobials.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1985 |
Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines | 1986 |
In vitro evaluation of A-56619 and A-56620, two new quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Piperazines; Quinolines | 1986 |
[In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
Topics: Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Pseudomonas aeruginosa; Quinolines; Topoisomerase II Inhibitors | 1985 |
Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors.
Topics: Anti-Bacterial Agents; Campylobacter; Drug Resistance, Microbial; Enoxacin; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Naphthyridines; Topoisomerase II Inhibitors | 1985 |
Clinical uses of nalidixic acid analogues: the fluoroquinolones.
Topics: Administration, Oral; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Evaluation; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Male; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Topoisomerase II Inhibitors | 1986 |
Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Humans; Nalidixic Acid; Norfloxacin; Ofloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1988 |
Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
Topics: Acinetobacter; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Haemophilus influenzae; Mezlocillin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 1985 |
Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Pipemidic Acid; Quinolines; Serratia marcescens | 1985 |
In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Enoxacin; Gentamicins; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin | 1985 |
Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Drug Evaluation; Enoxacin; Humans; Hydrogen-Ion Concentration; Models, Biological; Nalidixic Acid; Naphthyridines; Norfloxacin; Urinary Bladder; Urinary Tract Infections | 1985 |
In vitro activity of enoxacin compared with norfloxacin and amikacin.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Calcium; Drug Interactions; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Kanamycin; Magnesium; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1985 |
Antichlamydial activity of quinolone carboxylic acids.
Topics: Chlamydia trachomatis; Ciprofloxacin; Enoxacin; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1985 |
[Sensitivity of obligate anaerobes to ofloxacin, pefloxacin, enoxacin and norfloxacin].
Topics: Bacteria, Anaerobic; Bacteroides; Clostridium; Enoxacin; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1985 |
In-vitro activity of antifungal agents in combination with four quinolones.
Topics: 4-Quinolones; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Candida; Candida albicans; Ciprofloxacin; Drug Combinations; Enoxacin; Flucytosine; Mepartricin; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolines; Saccharomyces cerevisiae | 1988 |
The in-vitro activity of CI-934 compared with that of other new 4-quinolones and nalidixic acid.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Fluoroquinolones; Nalidixic Acid; Naphthyridines; Quinolines; Staphylococcus; Streptococcus | 1986 |
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
Topics: Acinetobacter; Aeromonas; Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin; Quinolines | 1986 |
Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
Topics: 4-Quinolones; Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Escherichia coli; Fluoroquinolones; Mutation; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1986 |
The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines; Quinolones; Structure-Activity Relationship; Urinary Tract Infections | 1985 |
In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents.
Topics: Anti-Bacterial Agents; Aztreonam; Clavulanic Acid; Clavulanic Acids; Enoxacin; Imipenem; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Piperacillin; Species Specificity; Thienamycins; Ticarcillin | 1985 |
Enoxacin: a potent inducer of filamentous Escherichia coli cells (a note).
Topics: Anti-Bacterial Agents; Enoxacin; Escherichia coli; Nalidixic Acid; Naphthyridines; Pseudomonas aeruginosa; Species Specificity; Staphylococcus aureus | 1985 |
Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.
Topics: Blood Bactericidal Activity; Ciprofloxacin; Culture Media; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Phagocytosis; Pipemidic Acid; Quinolines; Serratia marcescens; Topoisomerase II Inhibitors | 1984 |
Nalidixic acid analogues and Shigella.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Nalidixic Acid; Naphthyridines; Quinolines; Shigella | 1984 |
Characterization of two clinical, multiple-drug-resistant isolates of Enterobacter cloacae.
Topics: Adult; Animals; Anti-Bacterial Agents; Antigens, Bacterial; Bacteriocins; Blood Bactericidal Activity; Cephalosporinase; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Enoxacin; Enterobacter; Enterobacteriaceae; Female; Humans; Male; Mice; Nalidixic Acid; Naphthyridines; Norfloxacin; O Antigens; R Factors; Virulence | 1984 |
In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Stability; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pseudomonas | 1983 |
Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Enoxacin; Gentamicins; Male; Mice; Nalidixic Acid; Naphthyridines; Norfloxacin; Pipemidic Acid | 1983 |
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Autoradiography; Bile; Dogs; Enoxacin; Female; Kinetics; Macaca fascicularis; Male; Mice; Nalidixic Acid; Naphthyridines; Norfloxacin; Protein Binding; Rats; Rats, Inbred Strains; Species Specificity; Tissue Distribution | 1983 |
In vitro and in vivo antibacterial activity of AT-2266.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Enoxacin; Male; Mice; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Naphthyridines; Norfloxacin; Pipemidic Acid | 1983 |
In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Colony-Forming Units Assay; Drug Resistance, Microbial; Drug Synergism; Enoxacin; Microbial Sensitivity Tests; Mutagens; Nalidixic Acid; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Trimethoprim | 1983 |
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.
Topics: Anti-Bacterial Agents; Bacteria; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Nalidixic Acid; Naphthyridines; Norfloxacin; Oxolinic Acid; Pseudomonas aeruginosa; Quinolines | 1984 |
A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Microbial; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
In-vitro activity of enoxacin, ofloxacin, norfloxacin and nalidixic acid.
Topics: Bacteria; Bacterial Infections; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines | 1984 |
The pharmacokinetics and tissue penetration of enoxacin and norfloxacin.
Topics: Adult; Body Fluids; Enoxacin; Half-Life; Humans; Kinetics; Male; Nalidixic Acid; Naphthyridines; Norfloxacin; Tissue Distribution | 1984 |
In-vitro activity of enoxacin against aminoglycoside-resistant gram-negative bacilli and other clinical isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Pseudomonas aeruginosa; Staphylococcus | 1984 |
[The uptake of nalidixic acid and enoxacin by rat renal cortical slices in rat].
Topics: Animals; Cimetidine; Enoxacin; In Vitro Techniques; Ion Transport; Kidney Cortex; Male; Nalidixic Acid; Probenecid; Rats; Rats, Wistar | 1995 |
Correlation between umuC induction and Salmonella mutagenicity assay for quinolone antimicrobial agents.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; DNA-Directed DNA Polymerase; Enoxacin; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Mutagenicity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolones; Salmonella typhimurium; SOS Response, Genetics; Species Specificity | 1993 |
Susceptibility of Pseudomonas aeruginosa of various pyocin types to the newly synthesized ampicillin derivative, N-(6,7-difluoroquinolonyl)ampicillin.
Topics: Ampicillin; Ampicillin Resistance; Anti-Infective Agents; Drug Resistance, Microbial; Enoxacin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Penicillins; Pseudomonas aeruginosa; Pyocins | 1997 |
Photocleavage of DNA by the fluoroquinolone antibacterials.
Topics: Anti-Infective Agents; DNA Damage; Enoxacin; Fleroxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Photolysis; Plasmids; Quinolones; Structure-Activity Relationship; Ultraviolet Rays | 1998 |
Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli.
Topics: Anti-Infective Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ciprofloxacin; Diffusion; Dose-Response Relationship, Drug; Enoxacin; Enrofloxacin; Escherichia coli; Fluorescence; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nalidixic Acid; Pseudomonas aeruginosa; Quinolones; Spheroplasts; Staphylococcus aureus; Temperature | 1999 |
Application of derivative UV spectrophotometry for the determination of enoxacin and nalidixic acid in tablets.
Topics: Anti-Infective Agents; Calibration; Enoxacin; Indicators and Reagents; Nalidixic Acid; Regression Analysis; Spectrophotometry, Ultraviolet; Tablets | 2000 |
[Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Dermatitis, Phototoxic; Enoxacin; Female; Fluoroquinolones; Guinea Pigs; Nalidixic Acid; Ofloxacin; Oxazines; Quinolones; Rats; Rats, Sprague-Dawley; Ultraviolet Rays | 2002 |
Corneal and scleral permeability of quinolones--a pharmacokinetics study.
Topics: Administration, Topical; Animals; Aqueous Humor; Cell Membrane Permeability; Cinoxacin; Ciprofloxacin; Conjunctiva; Cornea; Enoxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones; Rabbits; Sclera; Time Factors; Water | 2003 |
Vibrational spectroscopic characterization of fluoroquinolones.
Topics: Aza Compounds; Cinoxacin; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Enoxacin; Enzyme Inhibitors; Fluoroquinolones; Hydrogen Bonding; Hydrogen-Ion Concentration; Models, Chemical; Models, Molecular; Models, Theoretical; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxolinic Acid; Quinolines; Quinolones; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Temperature; Ultraviolet Rays; Vibration; Water | 2005 |
T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigen-Presenting Cells; Aza Compounds; Cell Proliferation; Cells, Cultured; Ciprofloxacin; Clone Cells; Cross Reactions; Drug Hypersensitivity; Enoxacin; Female; Fluoroquinolones; Humans; Hypersensitivity, Delayed; Middle Aged; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Patch Tests; Pipemidic Acid; Quinolines; Quinolones; T-Lymphocytes | 2006 |
Selective action of fluoroquinolones against intracellular amastigotes of Leishmania (Viannia) panamensis in vitro.
Topics: Animals; Cell Line; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Leishmania guyanensis; Macrophages; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones | 2005 |